Clear Impact logo

Vermont Medicaid (Global Commitment) (GC-MY22)

HBD: Hemoglobin A1c Control for Patients with Diabetes in Poor Control (>9.0%) - Age 18-75 (GC-MY22)

Current Value

47.5%

MY 2022

Definition

Line Bar

Notes on Methodology

  • This is a Healthcare Effectiveness & Data Information Set (HEDIS®) hybrid measure.
  • The annual reported rate captures activity during the stated measurement year (MY).
  • The target trendline in the graph above represents the 25th national benchmark percentile for Medicaid programs across the country. 
  • In MY22, the Comprehensive Diabetes Care: Hemoglobin A1c (HbA1c) Poor Control (>9.0%) (HPC-AD) measure was modified by the measure steward into a combined measure that has two rates: HbA1C Control (<8%) and HbA1C Poor Control (>9%). The combined measure is called Hemoglobin A1c Control for Patients With Diabetes (HBD-AD).
  • Vermont Medicaid produces this measure using the hybrid methodology, which combines administrative claims data with information taken from medical records. The DVHA completed a medical record review for this measure for the first time in 2014. The diabetes in poor control measure was first produced by VT Medicaid in 2019.

The Healthcare Effectiveness Data and Information Set (HEDIS®) is a registered trademark of NCQA.

Story Behind the Curve

This measure assesses the percentage of members 18–75 years of age with diabetes (types 1 and 2) whose hemoglobin A1c (HbA1c) was at the following levels during the measurement year:

  • HbA1c control (<8.0%).
  • HbA1c poor control (>9.0%).

Diabetes is one of the most costly and highly prevalent chronic diseases in the United States. Diabetes is the seventh leading cause of death in the U.S. and killed approximately 84,000 people in 2018. Many complications such as heart disease, stroke, blindness, kidney failure and amputation can be prevented if diabetes is detected and addressed in the early stages. Controlling A1c blood levels helps reduce the risk of microvascular complications (eye, kidney and nerve diseases).

Last updated:  February 2024

Partners

  • Vermont Medicaid beneficiaries
  • Medicaid providers and Community Health Teams
  • Vermont Department of Health
  • Vermont Chronic Care Initiative

Action Plan

Vermont Chronic Care Initiative:

http://dvha.vermont.gov/for-providers/vermont-chronic-care-initiative-vcci

Vermont Department of Health - Diabetes Prevention and Control:

http://healthvermont.gov/prevent/diabetes/diabetes...

Footnote

NCQA’s Notice of Copyright and Disclaimers 
“The source for certain health plan measure rates and benchmark (averages and percentiles) data (“the Data”) is Quality Compass® 2022 and is used with the permission of the National Committee for Quality Assurance (“NCQA”). Any analysis, interpretation or conclusion based on the Data is solely that of the authors, and NCQA specifically disclaims responsibility for any such analysis, interpretation or conclusion. Quality Compass is a registered trademark of NCQA. 

The Data comprises audited performance rates and associated benchmarks for Healthcare Effectiveness Data and Information Set measures (“HEDIS® ”) and HEDIS CAHPS® survey measure results. HEDIS measures and specifications were developed by and are owned by NCQA. HEDIS measures and specifications are not clinical guidelines and do not establish standards of medical care. NCQA makes no representations, warranties or endorsement about the quality of any organization or clinician that uses or reports performance measures or any data or rates calculated using HEDIS measures and specifications, and NCQA has no liability to anyone who relies on such measures or specifications. 

NCQA holds a copyright in Quality Compass and the Data and can rescind or alter the Data at any time. The Data may not be modified by anyone other than NCQA. Anyone desiring to use or reproduce the Data without modification for an internal, noncommercial purpose may do so without obtaining approval from NCQA. All other uses, including a commercial use and/or external reproduction, distribution or publication, must be approved by NCQA and are subject to a license at the discretion of NCQA. © 2022 National Committee for Quality Assurance, all rights reserved. 

CAHPS is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).”

Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.

Scorecard Container Measure Action Actual Value Target Value Tag S A m/d/yy m/d/yyyy